In the clomethiazole acute stroke study (CLASS), a randomized, controlled trial of clomethiazole in 1,360 acute stroke patients, its efficacy was not significantly different from that of the placebo group [69]
"Stuck in a GLP-1 plateau
Ingredient List
But the benefits of peptide injections continue for days or even weeks depending on the protocol
2017 meta-analysis: A systematic review and meta-analysis of nine randomized controlled trials showed that ALCAR supplementation significantly decreased depressive symptoms compared to placebo (standardized mean difference 1.10, 95% CI 1.65 to 0.56), with effects comparable to established antidepressants like fluoxetine, particularly in older adults or those with treatment-resistant depression [5][30]
December 15, 2025: MDL Created for Ozempic Vision Loss Lawsuits In a significant move, the Judicial Panel on Multidistrict Litigation has approved the creation of a new MDL for Ozempic vision loss lawsuits